Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Episcleral Topotecan Chemoplaque in Retinoblastoma
NCT06679634Phase 2Recruiting
- Sponsor
- Targeted Therapy Technologies
- Start
- Feb 2025
- Primary completion
- Nov 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan in retinoblastoma (Rb), sponsored by Targeted Therapy Technologies. Started Feb 2025; status: recruiting.
02
Drugs
topotecan
03
Conditions
retinoblastoma (Rb)
Beyond the preview
Go deeper on NCT06679634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679634.